Courtney - Sorry about the delay.
The Univec warrants have been performing better recently; I expect the company to announce agreements with a number of UN related NGOs soon and this augers well for both stock and warrant.
Aid Auto Stores remains a sleeper; I can give you the normal BS about interesting prospects for AIDA etc., but check it out yourself. The company is reorganizing itself so as to own most its outlets; in the long term, the bottom line ramifications are distinctly positive. One thing is clear: they continue to attract investment capital and are in active negotiations to locate outlets in a large national retail chain.
Fountain Pharmaceuticals is another sleeper. Following an announcement earlier this year of a cash influx from an investment group (and a subsequent reorganization of the board), the stock has gone back to sleep. The company does not provide a lot of information on the product that caught my eye some time ago: a microencapsulation/drug delivery system. While there's some real potential here, I've not kept up with FPHI recently so I'm unaware if they've made progress in stabilizing their financial position.
Clearly, AIDA and FPHI are very high risk situations and my equity exposure in them is minimal. NURS also falls in this category although this stock has just recently shown breakout behavior. Compumed (CMPD) has recently introduced its newest line of portable imaging devices and the stock has had a nice run. In fact, CMPD may be the best current opportunity of all of these 'penny' stocks.
On a significantly higher quality level, Ariad Pharmaceuticals is a powerhouse biotech which will probably continue to tread water until the pipeline produces. You are probably familiar with Catellus Development Corp. - if you are of the ilk, CDX is probably the best avenue to access the revitalized CA. real estate mkt.
I also like Genicom (GECM), Mail-Well (MWL), and Wild Oats Markets (OATS).
Best wishes,
Peter |
